Cytocast
PrivateLast Round
Seed
Aug 1, 2023
Total Funding Raised
$2.05M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Cytocast is a biotechnology company that provides a drug discovery platform using computer simulations technology.
Sector
AI, Data & Cloud Infrastructure
Verticals
Drug Discovery, Biotechnology, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytocast Comparables
Compare Cytocast with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 88% | |
| DeepLife | 86% | |
| InSilicoTrials Technologies | 83% |
Cytocast Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2023 | ||||
| Grant | Sep 26, 2022 | ||||
| Pre Seed | Dec 1, 2021 |
Key People
Founding team and executive leadership
Cytocast Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bonitás Investment Fund Management | Seed |
| Creative Accelerator | Pre Seed, Seed |
| FastVentures | Seed |
| National Research, Development and Innovation Office (NKFIH) | Grant |
| Zoiros Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 49% MoM.
- Jul 20, 2026
Open roles increased to 5, 5x the trailing average.
Cytocast Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cytocast's valuation, stock price, and market status.
Is Cytocast a public or private company?
Cytocast is a private company.
What is the current stock price of Cytocast?
Cytocast is a private company with no public stock price. No recent secondary market data is available.
How much is Cytocast worth (valuation)?
Valuation information for Cytocast is not publicly available.
Can I buy Cytocast stock?
Cytocast shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cytocast's last funding round?
Cytocast's most recent funding round was Seed on August 1, 2023.
Who are the main investors in Cytocast?
Key investors in Cytocast include Bonitás Investment Fund Management, Creative Accelerator, FastVentures, National Research, Development and Innovation Office (NKFIH), Zoiros Ventures.
Will Cytocast IPO soon?
No public IPO plans have been announced for Cytocast.
How can I track Cytocast secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cytocast's secondary market activity and sign up for updates.